A national vaccination program against hepatitis B virus (HBV) to immunize every newborn was initiated in Taiwan in 1986. A serologic survey of 1,812 fully vaccinated children residing in four aboriginal villages and four adjacent nonaboriginal Han Chinese rural villages was conducted in 1993. Children in three of the four aboriginal villages had significantly lower titers of antibody against hepatitis B surface antigen (anti-HBs) than did children in the nonaboriginal villages. Evaluation of cold chain operation for vaccine storage and transport suggested that cold chain failure was not responsible for the fact that children residing in the more remote aboriginal villages had lower mean trters of anti-HBs. However, children whose parents w...
The prevalence of hepatitis B surface antigen (HBsAg) in a population aged 15 y or older was high in...
The world's first nationwide hepatitis B virus (HBV) universal vaccination program for infants was l...
Of 1,801 Chinese subjects, age 1 to 90 years, screened for hepatitis B surface antigen and antibody ...
The objective of this study was to determine long-term immunity to hepatitis B virus (HBV) in a coho...
To study the efficacy of immunization against hepatitis B after plasma- derived vaccine was replaced...
The objective of this study was to determine long-term immunity to hepatitis B virus (HBV) in a coho...
The prevalence rate of hepatitis B virus (HBV) infection in Pacific Island countries is amongst the ...
From August 1989 to may 1993, extensive studies on the epidemiology of hepatitis B virus (HBV) infec...
Several viral factors are associated with disease progression in hepatitis B virus HBV carriers. Com...
A hepatitis B mass immunization program was launched in Taiwan in July 1984, beginning with newborns...
Introduction: Thailand has integrated hepatitis B (HB) vaccination of newborns into the national Exp...
SummaryObjectiveThe hepatitis B vaccine was first introduced into the routine immunization program i...
A mass hepatitis B vaccination program began in Taiwan in 1984. In order to determine the immune sta...
BACKGROUND: Aboriginal and Torres Strait Islander people are disproportionately affected by hepatiti...
BACKGROUND: Indigenous populations globally are disproportionately affected by chronic hepatitis B v...
The prevalence of hepatitis B surface antigen (HBsAg) in a population aged 15 y or older was high in...
The world's first nationwide hepatitis B virus (HBV) universal vaccination program for infants was l...
Of 1,801 Chinese subjects, age 1 to 90 years, screened for hepatitis B surface antigen and antibody ...
The objective of this study was to determine long-term immunity to hepatitis B virus (HBV) in a coho...
To study the efficacy of immunization against hepatitis B after plasma- derived vaccine was replaced...
The objective of this study was to determine long-term immunity to hepatitis B virus (HBV) in a coho...
The prevalence rate of hepatitis B virus (HBV) infection in Pacific Island countries is amongst the ...
From August 1989 to may 1993, extensive studies on the epidemiology of hepatitis B virus (HBV) infec...
Several viral factors are associated with disease progression in hepatitis B virus HBV carriers. Com...
A hepatitis B mass immunization program was launched in Taiwan in July 1984, beginning with newborns...
Introduction: Thailand has integrated hepatitis B (HB) vaccination of newborns into the national Exp...
SummaryObjectiveThe hepatitis B vaccine was first introduced into the routine immunization program i...
A mass hepatitis B vaccination program began in Taiwan in 1984. In order to determine the immune sta...
BACKGROUND: Aboriginal and Torres Strait Islander people are disproportionately affected by hepatiti...
BACKGROUND: Indigenous populations globally are disproportionately affected by chronic hepatitis B v...
The prevalence of hepatitis B surface antigen (HBsAg) in a population aged 15 y or older was high in...
The world's first nationwide hepatitis B virus (HBV) universal vaccination program for infants was l...
Of 1,801 Chinese subjects, age 1 to 90 years, screened for hepatitis B surface antigen and antibody ...